Announced first-ever commercial installation of its AI-driven systems in a national railways line Achieved regulatory approval and certificate for railway…
SEATTLE, May 24, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company…